Heidy King-Jones
Chief Legal Officer and Corporate Secretary · Spyre Therapeutics, Inc.
- 2026
- Oct 3, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Heidy King-Jones files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $399.66M in SYRE purchases and sales in the last 12 months
- Cameron Turtle - $10.91M in SYRE purchases and sales in the last 12 months
- Scott L. Burrows - $9.12M in SYRE purchases and sales in the last 12 months
- Michael Thomas Henderson - $7.95M in SYRE purchases and sales in the last 12 months
- Sheldon Sloan - $7.35M in SYRE purchases and sales in the last 12 months
- Jeffrey W. Albers - $2.40M in SYRE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Heidy King-Jones?
Heidy King-Jones is a corporate insider, tracked as Chief Legal Officer and Corporate Secretary of Spyre Therapeutics, Inc. (SYRE). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Heidy King-Jones submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Heidy King-Jones been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($5.11M) across all tracked filings.
